Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q1 2026
Harvard Apparatus Regenerative Technology (HRGN) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $226K for the first quarter 2026 (Q1 2026), +402% from a year earlier and +3% from the quarter before. Operating margin was -710.6%, net loss $1.6M (708.4% of revenue).
Harvard Apparatus Regenerative Technology, Q1 2026: revenue $226K (+402% year over year), operating margin -710.6%, net loss $1.6M, operating cash flow −$937K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $226K | +3% | +402% |
| Operating profit | −$1.6M | — | — |
| Net earnings | −$1.6M | — | — |
| Operating cash flow | −$937K | — | — |
What changed
Revenue was $226K in Q1 2026, up 402% year over year and up 3% from the previous quarter.
Operating costs exceeded revenue by $1.6M, an operating margin of -710.6%. Total costs grew 7% against revenue growth of 402%. The fastest-growing cost line was Cost of revenue (+524%). The quarter ended with a net loss of $1.6M, narrower than the previous quarter's $1.7M loss.
Operating cash flow was −$937K. Non-cash charges added back $1K of depreciation and $632K of share-based compensation.
Questions
What was Harvard Apparatus Regenerative Technology's revenue in the first quarter 2026?
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $226K for the first quarter 2026 (Q1 2026), +402% from a year earlier and +3% from the quarter before.
Was Harvard Apparatus Regenerative Technology profitable in the first quarter 2026?
Operating loss was $1.6M (-710.6% of revenue) and net loss $1.6M.
Source: Harvard Apparatus Regenerative Technology 10-Q on SEC EDGAR.